Compare NeoGenomics Inc. Common Stock (NEO) vs Cactus Inc. Class A Common Stock (WHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Cactus Inc. Class A Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Cactus Inc. Class A Common Stock trades at $62.37 (market cap $5.02B). The key difference: Cactus Inc. Class A Common Stock is far larger — about 2.3× NeoGenomics Inc. Common Stock's market cap, and Cactus Inc. Class A Common Stock pays a 0.96% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Cactus Inc. Class A Common Stock for 0 Days on average.
| NEO | WHD | |
|---|---|---|
Market Cap | $2.17B | $5.02B |
Volume | 1,615,943 | 804,573 |
Sector | Health | Energy |
52-Week High | $19.91 | $73.73 |
52-Week Low | $7.19 | $35.26 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.47B | $4.71B |
Dividend Yield | — | 0.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Cactus Inc. Class A Common Stock
Cactus Inc. designs, manufactures, and rents wellhead and pressure control equipment for oil and gas drilling, completion, and production, operating under the Cactus Wellhead brand.
Read more on WHD →
